In terms of the Code of Conduct to regulate, monitor and report Trading by Insiders of the company, Albert David has informed that the Trading Window for purchase/sale/dealing in the shares of the Company, shall remain closed for Insiders/Designated Persons of the Company (and their immediate relatives) commencing from Sunday, the 1st October, 2023. The Trading Window will open after 48 hours from the declaration of the Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30 September, 2023. The date of the Board meeting of the Company for consideration and approval of Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2023 will be intimated in due course. The aforesaid information is also available on the website of the Company at www.albertdavidindia.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: